Agency’s Objection to $1.2B PacBio Acquisition Won’t Weaken Sequencing Giant, Market Watchers Tell GEN Edge The U.S. Federal Trade Commission (FTC) challenge to Illumina’s planned $1.2 billion …
More Deal or No Deal: FTC Challenge Poses No Threat to Illumina, Analysts Agree Videos